v3.25.4
Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Series A Convertible Preferred Stock
Series B Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Convertible Preferred Stock, beginning balance at Dec. 31, 2023   $ 89,487 $ 77,091        
Convertible Preferred Stock, beginning balance, shares at Dec. 31, 2023   100,182,354 51,273,790        
Beginning balance at Dec. 31, 2023 $ (25,634)     $ 4 $ 19,796 $ 4 $ (45,438)
Beginning balance, shares at Dec. 31, 2023       4,170,817      
Issuance of Series B convertible preferred stock for the settlement of the tranche right liability, net of issuance costs 7,343   $ 68,161   7,343    
Issuance of Series B convertible preferred stock for the settlement of the tranche right liability, net of issuance costs, shares     38,157,240        
Conversion of Series A convertible preferred stock to common stock upon closing of the intial public offering 89,487 $ (89,487)   $ 12 89,475    
Conversion of Series A convertible preferred stock to common stock upon closing of the intial public offering, shares   (100,182,354)   11,701,298      
Conversion of Series B convertible preferred stock to common stock upon closing of the initial public offering 145,252   $ (145,252) $ 10 145,242    
Conversion of Series B Convertible Preferred Stock to Common Stock Upon Closing of the Initial Public Offering, Shares     (89,431,030) 10,445,518      
Issuance of common stock from initial/underwritten public offering, net of issuance costs 140,868     $ 9 140,859    
Issuance of common stock from initial/underwritten public offering, net of issuance costs, shares       9,200,000      
Issuance of common stock from private placement, net of issuance cost 16,702     $ 1 16,701    
Issuance of common stock from private placement, net of issuance cost, shares       1,058,824      
Issuance of common stock upon exercise of stock options 7     $ 1 6    
Issuance of common stock upon exercise of stock options, shares       3,745      
Stock-based compensation expense 10,235       10,235    
Net loss (78,307)           (78,307)
Change in unrealized gain (loss) on investments, net of tax (526)         (526)  
Ending balance at Dec. 31, 2024 $ 305,427     $ 37 429,657 (522) (123,745)
Ending balance, shares at Dec. 31, 2024 36,580,202     36,580,202      
Issuance of common stock from initial/underwritten public offering, net of issuance costs $ 269,439     $ 11 269,428    
Issuance of common stock from initial/underwritten public offering, net of issuance costs, shares       11,057,692      
Issuance of common stock upon exercise of stock options $ 1,348       1,348    
Issuance of common stock upon exercise of stock options, shares 192,864     192,864      
Stock-based compensation expense $ 18,855       18,855    
Vesting of performance-based restricted stock units, shares       34,750      
Repurchase of unvested restricted common stock (1)       (1)    
Repurchase of unvested restricted common stock, shares       (92,941)      
Net loss (111,483)           (111,483)
Change in unrealized gain (loss) on investments, net of tax 1,068         1,068  
Ending balance at Dec. 31, 2025 $ 484,653     $ 48 $ 719,287 $ 546 $ (235,228)
Ending balance, shares at Dec. 31, 2025 47,772,567     47,772,567